AbbVie is a new biopharmaceutical company with the expertise and financial performance of an established pharmaceutical leader. Through a targeted, patient-centric approach to research & development, AbbVie accelerates new scientific discoveries to address some of the most complex diseases and contribute to the sustainability of health care systems around the world.
Here's a high-level overview about our business.
|Chairman and CEO||Richard A. Gonzalez|
|Corporate Headquarters||North Chicago, Illinois, USA|
|Business||Specialty-focused, research-based biopharmaceutical company|
|Stock Exchange Listing||New York [ABBV:NYSE]|
|2016 Revenue||$25.6 billion|
AbbVie is a global healthcare company whose passion lies in developing advanced therapies to address the world’s most difficult health problems.
Visit our US products page for prescribing information »
Lake County, Illinois, USA
Worcester, Massachusetts, USA
Redwood City, California, USA
Sunnyvale, California, USA (Pharmacyclics)
Cambridge, Massachusetts, USA (Neuroscience)
South San Francisco, California USA (Stemcentrx)
Focus on immunology, oncology, neurology, virology
|Countries Where Our Products Help Patients||175+|
|Primary Research and Manufacturing Facilities||21|